Filing Details
- Accession Number:
- 0001209191-10-043440
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-19 13:00:00
- Reporting Period:
- 2010-08-17
- Filing Date:
- 2010-08-19
- Accepted Time:
- 2010-08-19 19:43:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197018 | Anthony N Coles | C/O Onyx Pharmaceuticals, Inc. 2100 Powell St. Emeryville CA 94608 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-08-17 | 7,375 | $26.96 | 75,927 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-19 | 12,625 | $26.08 | 63,302 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares were sold to cover a tax obligation realized by the reporting person that arose in connection with the vesting of the underlying restricted stock award.
- Includes 736 shares purchased through the issuer's ESPP.
- Shares were a restricted stock award sold by the reporting person for the purchase of a local residence.
- The shares were sold between $26.00 and $26.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
